DIY Transplant
-
Man Says He Developed Mother’s Menopause Symptoms After At-Home Fecal Transplant
The DIY transplant was definitely not approved by a doctor
An at-home fecal transplant regimen led to unexpected side effects for one man.
Charlie Curtis, who is in his mid-30s and lives in Toronto, Canada, chronicled his highly unusual tale to filmmaker Saffron Cassaday for her documentary called “Designer $hit,” Business Insider reported Tuesday.
Curtis had struggled with severe Crohn’s disease, which he developed after a bout of ulcerative colitis in 2006. Crohn’s disease is a chronic condition that causes painful inflammation in one’s digestive tract, usually the small intestine. Symptoms include pain, fatigue, diarrhea, malnutrition and weight loss. There is currently no cure for the condition.
Curtis’s mother, Sky Curtis, told Cassaday that at one point he was hospitalized and was using the bathroom 40 times a day. After reaching out to Thomas Borody, M.D., who began doing fecal transplants in 1988, he suggested that Sky donate some of her healthy fecal matter to her son.
Currently, fecal transplants are only approved by the Food and Drug Administration (FDA), as well as Canadian health regulators, as a treatment for persistent infections of clostridium difficile, or C.diff, a bacterial infection that is common in hospitals and is often antibiotic resistant, making it difficult to cure.
C. diff is a bacteria that can grow out of control in some people’s digestive systems in the absence of bacteria that usually keep it in check. This can cause life-threatening diarrhea and colon inflammation. Fecal microbiota transplants, commonly shortened to just fecal transplants, aim to restore the population of the bacteria that control the growth of C. diff when nothing else worked.
-
Man Says He Developed Mother’s Menopause Symptoms After At-Home Fecal Transplant
The DIY transplant was definitely not approved by a doctor
An at-home fecal transplant regimen led to unexpected side effects for one man.
Charlie Curtis, who is in his mid-30s and lives in Toronto, Canada, chronicled his highly unusual tale to filmmaker Saffron Cassaday for her documentary called “Designer $hit,” Business Insider reported Tuesday.
Curtis had struggled with severe Crohn’s disease, which he developed after a bout of ulcerative colitis in 2006. Crohn’s disease is a chronic condition that causes painful inflammation in one’s digestive tract, usually the small intestine. Symptoms include pain, fatigue, diarrhea, malnutrition and weight loss. There is currently no cure for the condition.
Curtis’s mother, Sky Curtis, told Cassaday that at one point he was hospitalized and was using the bathroom 40 times a day. After reaching out to Thomas Borody, M.D., who began doing fecal transplants in 1988, he suggested that Sky donate some of her healthy fecal matter to her son.
Currently, fecal transplants are only approved by the Food and Drug Administration (FDA), as well as Canadian health regulators, as a treatment for persistent infections of clostridium difficile, or C.diff, a bacterial infection that is common in hospitals and is often antibiotic resistant, making it difficult to cure.
C. diff is a bacteria that can grow out of control in some people’s digestive systems in the absence of bacteria that usually keep it in check. This can cause life-threatening diarrhea and colon inflammation. Fecal microbiota transplants, commonly shortened to just fecal transplants, aim to restore the population of the bacteria that control the growth of C. diff when nothing else worked.
@George-K said in DIY Transplant:
After reaching out to Thomas Borody, M.D., who began doing fecal transplants in 1988, he suggested that Sky donate some of her healthy fecal matter to her son.
From Wikipedia:
In 2020, Borody announced that he had discovered a "cure" for COVID-19: a combination of ivermectin, doxycycline and zinc. In a media interview Borody stated "The biggest thing about this is no one will make money from this".[2]
It later emerged that Topelia Australia, Borody's company, had filed a patent for the drug combination.[2][6] Borody was publicly accused of not adequately disclosing his conflict of interest. Wendy Lipworth from The University of Sydney's Health Ethics Centre described such behaviour as "blatantly unethical". Borody, via lawyers, denied wrongdoing.